Be part of the knowledge.™

NeuroFrontiers

Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.

So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.

265

LikeLikedUnlike

136-150 of 343

Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
NeuroFrontiers
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
- Natalie Bareis, PhD, LMSW
  Peer
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
NeuroFrontiers
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
- Natalie Bareis, PhD, LMSW
  Peer
Fatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
NeuroFrontiers
Fatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
NeuroFrontiers
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
Caring for Women with MS: Key Considerations for Pregnancy and Menopause
NeuroFrontiers
Caring for Women with MS: Key Considerations for Pregnancy and Menopause
Differentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
NeuroFrontiers
Differentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
- Maxwell H. Levy, MD
  Peer
advertisement
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
NeuroFrontiers
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
- Steven Paul, MD
  Peer
Navigating Myasthenia Gravis in Adolescents and Young Adults
NeuroFrontiers
Navigating Myasthenia Gravis in Adolescents and Young Adults
- Jonathan Strober, MD
  Peer
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
NeuroFrontiers
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
- Gil I. Wolfe MD, FAAN
  Peer
Challenges in DMD: Understanding the Height Factor
NeuroFrontiers
Challenges in DMD: Understanding the Height Factor
The Evolving gMG Treatment Landscape
NeuroFrontiers
The Evolving gMG Treatment Landscape
- Henry Kaminski, MD
  Peer
FcRn Inhibitors: A Potential New Targeted Therapy Option
NeuroFrontiers
FcRn Inhibitors: A Potential New Targeted Therapy Option
- Nicholas J. Silvestri, MD
  Peer
advertisement
Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
NeuroFrontiers
Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
Unseen Struggles: Impacts of Homelessness on Women with Schizophrenia
NeuroFrontiers
Unseen Struggles: Impacts of Homelessness on Women with Schizophrenia
NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
NeuroFrontiers
NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy

Program Chapters

Segment Chapters

Playlist:

Recommended